Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?-Reference-Cited by-同舟云学术

Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?

Published:2022-07 Issue:7 Volume:28 Page:392.e1-392.e9
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Jodele Sonata,Dandoy Christopher E.,Sabulski Anthony^ORCID,Koo Jane^ORCID,Lane Adam,Myers Kasiani C.,Wallace Gregory^ORCID,Chima Ranjit S.,Teusink-Cross Ashley,Hirsch Russel^ORCID,Ryan Thomas D.^ORCID,Benoit Stefanie^ORCID,Davies Stella M.

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference18 articles.

1. Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management;Dvorak;Front Pediatr,2019

2. Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT;Moiseev;Bone Marrow Transplant,2019

3. A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant;Dandoy;Blood Adv,2021

4. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults;Jodele;Blood,2014

5. Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients;Jodele;Expert Rev Hematol,2021

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC);Transplantation and Cellular Therapy;2024-06

2. Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation—A secondary CIBMTR analysis;British Journal of Haematology;2024-05-30

3. Neurological involvement in hematopoietic stem cell transplantation-associated thrombotic microangiopathy;Annals of Hematology;2024-05-20

4. D‐dimer and sinusoidal obstructive syndrome‐novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study;American Journal of Hematology;2024-01-02

5. Eculizumab: Inhibiting C5 Earns a High Five in Prospective Pediatric, Multicenter, High-risk Transplant-associated Thrombotic Microangiopathy Study;The Hematologist;2024